Studies Find Resistance Mechanisms in ALK+ and ROS1+ Cancers

Two University of Colorado Cancer Center studies published in Clinical Cancer Research define genetic changes that allow ALK+ and ROS1+ cancers to resist treatment, and demonstrate the ability to…

(PRWeb April 11, 2018)

Read the full story at http://www.prweb.com/releases/2018/04/prweb15404824.htm